Chris Duncan Passes Away
Former Cardinals outfielder Chris Duncan passed away Friday after a prolonged battle with brain cancer. The son of former St. Louis pitching coach Dave Duncan and younger brother of former Yankee Shelley Duncan, Chris was diagnosed with glioblastoma in 2012 and took a leave of absence from his ESPN radio show in January. He was 38 years old. MLBTR joins those around the game in expressing our deepest sympathies to the Duncan family.
The Cardinals organization issued a statement on Twitter: “We are deeply saddened by the passing of Chris Duncan after his courageous battle against brain cancer. We extend our heartfelt sympathies to his wife, Amy, the entire Duncan family, and his many friends.”
Duncan played his entire career with the Cardinals from 2005 to 2009, finishing with marks of .257/.348/.458 across 1317 plate appearances and 389 career games. He hit 43 of his 55 career home runs over the 2006 and 2007 seasons, winning a World Series with the 2006 Cardinals. Duncan was a big part of that 2006 title team, as he chipped in a red-hot second half, hitting .295/.374/.604 with 19 homers after the All-Star break. Dave Duncan was the pitching coach for that ball club, helmed by Tony La Russa, which snuck into the playoffs with just 83 wins.
In recent years, Duncan became a popular radio personality in St. Louis, chronicled in a great piece about his passing by Derrick Goold of the St. Louis Post-Dispatch.
Javier Baez Has Hairline Fracture In Thumb, Timeline Unclear
An MRI today revealed that Cubs shortstop Javier Baez has a hairline fracture in his left thumb, per Jesse Rogers of ESPN. He’ll visit a specialist on Monday for further evaluation. Though the Cubs have yet to release a timeline for his return, it’s possible that this could mean the end of the season for the star infielder.
Baez has missed the last four games after suffering the injury while sliding into second base on September 1. Initial X-rays came back negative and Baez sought to return to the lineup on Thursday, but the persistence of discomfort during batting practice forced him to sit out as the team scheduled a follow-up MRI. Saturday night’s matchup with the Brewers will mark the fifth consecutive game without Baez in the lineup.
Though any injury this late in the season spells trouble for a playoff-hopeful club, this feels especially devastating for the Cubs. Baez has rightfully garnered a reputation as the lifeblood of the Cubs, not only as a mainstay in the middle of the batting order, but as one of the finest defensive infielders in baseball. By Baseball-Reference’s measure of WAR, he has been the most valuable Cub this season, a repeat of last year’s breakout.
Without Baez, Addison Russell is next in line to man the shortstop position. While his defensive talent at the position rivals that of Baez, it’s undebatable that his offensive production leaves much to be desired. If the Cubs, who find themselves in the heat of a contested playoff race, are to overtake the first-place Cardinals, Russell and the rest of the Cubs will need to pick up the slack. If indeed Baez is forced to miss the remainder of the season, it’s an injury that could have a significant impact on the National League Wild-Card chase.
This season, Baez has slashed .281/.316/.532 and has slugged 29 home runs, doubling down on the power surge that carried him to a second-place MVP finish a year ago. On defense, he’s tallied 15 DRS and earned a 9.6 Ultimate Zone Rating, both of which place him among the three best defensive shortstops in baseball.
Cubs To Promote Danny Hultzen, Designate Taylor Davis
Sept. 7: Hultzen’s contract has officially been selected. In order to clear a spot on the 40-man roster, the Cubs have designated Taylor Davis for assignment.
Sept. 6: It has been a long and winding road for former first-round draft pick Danny Hultzen, but the path will finally pass through the majors. The Cubs southpaw has received his first MLB promotion, according to Brett Taylor of Bleacher Nation (via Twitter).
Hultzen, 29, was the second overall pick of the 2011 draft after excelling at the University of Virginia. He was seemingly breezing through the Mariners farm system when a spiraling series of injuries completely derailed his career.
It seemed like a longshot that Hultzen would be able to get back to functioning on the mound, let alone thriving. But he has opened eyes in 14 1/3 innings this year at Triple-A, allowing just two earned runs on a paltry four hits while racking up 23 strikeouts against nine walks.
Calling up Hultzen will require the Cubs to clear a place on the 40-man roster. The corresponding move isn’t yet known.
Orioles Recall Austin Hays
The Orioles are set to promote outfielder Austin Hays to the Major League roster, according to Roch Kubatko of MASN. The touted 24-year-old will have his second crack at the big league level after a brief stint in 2017.
After a monster 2017 performance that ultimately earned him that promotion, Hays has struggled with injuries over the last two seasons, delaying his track to the majors and interrupting his development. He’s thus far failed to replicate the production that put him on the map two years ago, but the Orioles are hoping to unearth that offensive potential with another big-league tryout.
Many assumed that Hays wouldn’t suit up for the Orioles and would instead report to the Arizona Fall League in mid-September. However, it appears that Baltimore’s plans for its No. 6-ranked prospect have changed, in part thanks to a new rule that allows 40-man players to report to the AFL partway through the season. That means that Hays will have a chance to get big-league reps for the remainder of the O’s season before traveling West to compete with other top prospects.
Hays has drawn praise from MLB.com’s Jim Callis and Jonathan Mayo for his explosive offensive skills, including the bat speed and control necessary to start at a corner outfield spot. An aggressive approach has meant that Hays features a low walk rate, though he is able to make frequent contact. With a strong arm, Hays seems best suited for right field, though he’ll need to hit for both average and power to earn his keep.
Mets Activate Jed Lowrie
The Mets are set to welcome one of their offseason additions, as infielder Jed Lowrie has been activated from the injured list, according to Tim Healey of Newsday. In addition, Dominic Smith has been transferred to the 60-day injured list and right-hander Drew Gagnon has been recalled from Triple-A.
Lowrie, one of the Mets’ significant signings of the offseason, has yet to play a game in his new uniform due to a series of left leg injuries affecting the knee, hamstring, and calf. Lowrie, 35, inked a 2-year, $20MM contract with the Mets but began the season on the injured list with a left knee capsule strain that emerged in Spring Training. However, a hamstring strain in May delayed the timetable for his recovery, and it seems that rehab subsequently snowballed into a complicated mess of recovery and re-injury.
With Robinson Cano and Todd Frazier installed at second and third base, respectively, it’s unclear just how much playing time Lowrie will receive. In that regard, not much has changed since Lowrie was signed, when the fit appeared questionable, given the team’s invested in Cano and the presence of promising youngster Jeff McNeil. At the very least, he’ll be able to offer some return on the first year of the Mets’ investment. He’s coming off a pair of productive seasons in Oakland, posting a cumulative OPS of .804, including a career-best 23 home runs last season. While he likely isn’t at full health yet, the Mets will hope for signs that Lowrie isn’t far off those numbers—not only for this season, but with an eye on 2020 as well.
Meanwhile, Smith may very well have played his last game this season; now on the 60-day IL, the earliest he could return would come in the final week of the regular season. If indeed his season is over, he’ll close the book on a breakthrough age-24 season in which he has slashed .278/.352/.506 in a part-time role. However, Anthony DiComo of MLB.com reports that there’s a chance he could be cleared to make another appearance or two, as he’ll be reevaluated in his recovery from a stress fracture in his left foot.
Michael Pineda Receives 60-Game PED Suspension
Minnesota Twins right-handed pitcher Michael Pineda has been suspended for 60 games for violating MLB’s drug policy, reports Jon Heyman of MLB Network. He’ll miss the remainder of the season and is not eligible for postseason play.
Per Do-Hyoung Park of MLB.com, the 30-year-old Pineda tested positive for hydrochlorothiazide, a diuretic on MLB’s list of banned substances. Though that diuretic itself is not a performance-enhancing drug, it is often used in conjunction with PEDs for a masking effect. ESPN’s Jeff Passan adds that Pineda was initially tagged with an 80-game ban—standard procedure for first-time offenders—but an appeal brought that number down to 60 after providing evidence that the substance in Pineda’s system was not used as a masking agent for PEDs.
After undergoing Tommy John surgery in July 2017, Pineda caught on with the Twins on a two-year deal worth $10MM. Forced to sit out the entire 2018 season, Minnesota knew that it was only paying for one healthy season of Pineda, and his rebound has certainly been a respectable one. Though by no means a top-tier starter, he’s added depth to a Twins rotation that desperately needed it. He’s slotted in as the Twins third-best starter, posting a 4.01 ERA while racking up 146 innings for a playoff team. This year, he’s struck out 140 batters compared to just 28 walks, good for a clean 5.00 K:BB ratio.
His numbers have been even better over the last three-plus months, though, as it presumably took some time for the ex-Yankee to regain his feel for pitching after a lost season. Since the calendar turned to June, Pineda is sporting a sterling 3.10 ERA while striking out more than a batter per inning. During that stretch, he has indeed been the most reliable Minnesota starter.
However, that production will now be absent from any October games, with the suspension rendering Pineda ineligible for postseason play. That represents a considerable blow for the Twins, whose rotation has greatly benefited from the solid second-half presence of Pineda. Jose Berrios and Jake Odorizzi are an All-Star pairing, and Pineda would have given the Twins the makings of a respectable playoff rotation.
Instead, Kyle Gibson and Martin Perez will be relied upon to comprise half of that unit. Though Gibson and Perez have been valuable to the Twins in their own right, both have graded out a notch below Pineda, a disparity that could be magnified in a short series where pitching is often king. Gibson, currently on the injured list, is the more reliable of that duo: his 4.04 FIP compares favorably to Pineda’s and he owns a better track record of solid production. Perez, meanwhile, has made considerable adjustments to increase his staying power, though he still struggles with command and inconsistency. He is sporting just a 1.98 K:BB ratio to go with a 4.75 ERA.
Pineda issued a statement regarding his suspension through the MLB Players Association.
Giants Claim Wandy Peralta
The Giants have claimed left-handed pitcher Wandy Peralta off waivers from the Reds, according to C. Trent Rosecrans of The Athletic. He’ll report to his new club on Monday, tweets Andrew Baggarly of The Athletic, adding that the Giants have placed infielder Zach Green on the 60-day injured list thanks to a hip impingement.
Peralta has thrown 34 innings for the Reds this year, striking out 27 batters and walking 15 en route to a 6.09 ERA. He hasn’t been able to duplicate the success he generated in 2017, but he’ll have a chance for a change of scenery as he joins the stable of Giants relievers for a September tryout.
MLB, Players Association Discuss Prospect Of Mandated Opioid Testing
Major League Baseball and the Players Association have no shortage of topics to talk about these days, but a new issue has forced its way onto the agenda: opioid testing. The autopsy results after the tragic passing of Tyler Skaggs turned this national conversation into a touch point for MLB, and the two sides are discussing the possibilities of including random screenings for opioids into the official drug testing program, per Bill Shaikin of the Los Angeles Times.
Opioids do appear on the banned-substance list – a fine first step – but major league players aren’t subject to testing without reasonable cause. Tony Clark, the executive director of the Players Association, released a statement last Friday in which he said: “For several reasons, including the tragic loss of a member of our fraternity and other developments happening in the country as a whole, it is appropriate and important to reexamine all of our drug protocols relating to education, treatment and prevention.”
As drug testing has been an area of relative common ground in recent years, an accord here could inject a note of harmony to a negotiation largely fraught with skepticism. Even so, don’t expect anything contractual in the near-term. The opioid crisis is but one issue among many being discussed in the lead up to CBA negotiations in 2021. MLB and the Players Association are meeting about once a month for these “early negotiations,” per The Athletic’s Evan Drellich. While these sessions could not be more foundational to the overall discussions, the goal of diplomacy at this stage is more to about gauging temperature than putting pen to paper.
Both sides cite player welfare as a primary objective of these preliminary talks, though at present, there’s little reason to suspect pervasive use of opioids throughout the game. What information they do have comes from mandated testing for minor leaguers, who lack union protection and therefore are subject to testing and discipline by the commissioner’s office. More than 78,000 tests have been conducted for minor league players, resulting in just 12 suspensions, per ESPN.com’s Jeff Passan.
Still, fentanyl is the leading cause of overdose deaths in the U.S., and the Skaggs autopsy provided an opportunity to be proactive. The rate and severity of injury puts players at risk for exposure through short-term surgical use, and most players certainly have the financial means to foster ongoing abuse should it become an issue. There is likely to be stronger solution in the new CBA, as leaving the safety of players to the discretion of team doctors is hardly the most comprehensive approach, not to mention the burden of responsibilities it places on the doctors themselves.
White Sox Promote Mike Shirley To Director Of Amateur Scouting
The Chicago White Sox promoted Mike Shirley to be their new Director of Amateur Scouting, per Tom Musick of the Chicago Sun Times. The move continues a bit of organizational reshuffling, as Shirley assumes the post vacated by Nick Hostetler, who himself took a new position as special assistant to GM Rich Hahn.
Shirley becomes the point man for June’s annual draft. It’s a tough assignment in some ways, as expectations will be high after the tremendous job the White Sox have done in recent years in building the #3 ranked farm system, per Baseball America. Optics should be good for a couple of years while these recent picks graduate to the majors, guys like Nick Madrigal, Zack Collins, and Andrew Vaughn, high draft picks who are either in the majors now or on their way.
In an article from The Athletic’s James Fegan, Chicago’s new Director of Amateur Scouting spoke about their prospects for the upcoming 2020 draft.“There are a lot of good players out there,” Shirley said. “The game has changed. The younger players have a lot more impact today for a reason. The kids are more advanced at younger ages. We know that and I think that’s an exciting part of what baseball is becoming.”
That jives with the direction the franchise has taken in recent drafts, as they’ve begun to take more chances on high school players. Shirley will be tasked with maintaining a high degree of success, but he’s likely running out of ultra-high draft choices with which to work. With a record of 62-79, the White Sox are in line for a late top-10 pick in next June’s draft, but if all goes according to plan, this could be the last time picking in the top-10 for quite some time.
AL Injury Notes: Cruz, Gurriel, Springer
The Twins fell 6-2 in 11 innings to their chaser in the AL Central last night, yet they remain 5 1/2 games ahead of the Indians for the division crown. Minnesota is just 6-8 head-to-head against their eastern rival with five matchups remaining, all in the next ten days. More troublesome to the Twins, they may be without Nelson Cruz for at least these next couple showdowns. Cruz exited the ballgame in the tenth inning with wrist soreness, but he’s being listed as day-to-day, per MLB.com’s Do-Hyoung Park (via Twitter). Cruz carries an MVP-caliber bat when he’s healthy, arguably the best DH in the game with a .305/.385/.631 mark that pairs nicely with his traditional counting stats of 35 home runs and 92 RBIs. The wrist has been an issue for Cruz, however, as it’s already landed him on the IL twice. He was diagnosed with a ruptured ECU tendon back in March, but manager Rocco Baldelli insists the injury is nothing significant, tweets The Athletic’s Dan Hayes. Even minor injuries can have significant impact this time of year, of course, so let’s check in on a couple of injury scares for Minnesota’s potential dance partner in the upcoming ALDS.
- Yuli Gurriel‘s thunderous second half in Houston should return after just a brief interlude. The Astros first baseman left yesterday’s game with left hamstring discomfort, but he is considered day-to-day, per Mark Berman of Fox Houston. After authoring marks of .277/.314/.482 in the first half that fell just far enough below his career averages to spark fears of age-based decline for the 35-year-old, Yuli came out with a blistering second half: .351/.409/.660, pulling his overall productivity mark up to 135 wRC+, the 23rd highest mark in the majors. Gurriel’s leveling up paired with the arrival of Yordan Alvarez has made an already-strong Astros lineup certifiable.
- In a separate tweet, Berman provides video of George Springer taking batting practice and having himself a time. This should be a welcome sight for the Houston faithful, who saw Springer suffer a mild concussion while colliding into the wall Tuesday night. It’s been a career year for Springer in this, his age-28 season, as he’s put up his most complete season to date with a line of .297/.389/.573. His 155 wRC+ pegs him as the 7th most-productive hitter in the majors this season, joining four of his Houston brethren in the top-25 among qualified hitters (Alvarez doesn’t yet qualify). From the looks of it, Springer should return to the Houston lineup shortly.